Back

Diagnosis and the window for cure: imaging, biomarkers, and gene-carrier screening

28 August 2026 (08:33 - 08:51)
Organised by: Logo
Congress Presentation Part of: Frontiers in amyloid heart disease: from treatment to cure Cardiac Amyloidosis ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Esther Gonzalez Lopez

Hospital Universitario Puerta De Hierro Majadahonda, Madrid (Spain)

4 More presentations in this session

Presentation thumbnail
Why amyloid heart disease became treatable: TTR biology and the therapeutic ladder
Doctor L. Obici (Pavia, IT)
Slides Video
Presentation thumbnail
Silencing TTR: siRNA and antisense in the clinic
Doctor M. Maurer (New York, US)
Slides Video
Presentation thumbnail
Clearing deposited amyloid: antibody-based depletion
Doctor P. Garcia-Pavia (Majadahonda, ES)
Slides Video
Presentation thumbnail
Gene editing: can CRISPR cure ATTR?
Doctor J. Gillmore (Greater London, GB)
Slides Video

Access the full session

Session thumbnail
Frontiers in amyloid heart disease: from treatment to cure
Video

The Event

Event poster

ESC Congress 2026

28 August 2026 08:33 CET
You may be interested in
thumbnail
Congress Presentation
Novel tracers to improve transthyretin amyloidosis diagnostics
28 August 2026
thumbnail
Congress Presentation
Screening and early diagnosis: progress so far and the road ahead
9 May 2026
thumbnail
Congress Presentation
Therapy selection based on imaging
28 August 2026
thumbnail
Congress Presentation
Optimising treatment decisions: personalising ATTR-CM treatment in real-world practice
28 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources